A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Administered as Intramuscular Injection to Healthy Children 15 Months to 6 Years of Age

Clinical trial NCT07406360 · RECRUITING

Trial details

NCT number: NCT07406360
Sponsor: GlaxoSmithKline
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Measles Measles-Mumps-Rubella+Chickenpox Vaccine

Start date: 2026-05-11
Primary completion: 2028-02-28
Enrollment: 1209

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.